
Keywords: CM, cardiomyocytes; EHT, engineered heart tissue; hESC, human embryonic stem cells; hiPSC, human induced pluripotent stem cells; MEA, multi electrode array; T2, relaxation timeDrug development; Cardiac safety pharmacology; Screening assays; Human induced